- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.10. | Bone Biologics Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 13.10. | NSE - Bone Biologics Corp - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
| 29.09. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 16.09. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 08.09. | BONE BIOLOGICS CORPORATION: Bone Biologics Expands Trial Sites | 2 | GlobeNewswire (USA) | ||
| 14.08. | Bone Biologics Corp - 10-Q, Quarterly Report | 12 | SEC Filings | ||
| 23.07. | BONE BIOLOGICS CORPORATION: Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities | 416 | GlobeNewswire (Europe) | BURLINGTON, Mass, July 23, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) ("Bone Biologics" or the "Company"), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| BONE BIOLOGICS Aktie jetzt für 0€ handeln | |||||
| 16.07. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 09.07. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 08.07. | Bone Biologics enters into definitive agreement for $3.0M private placement | 1 | Seeking Alpha | ||
| 08.07. | BONE BIOLOGICS CORPORATION: Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules | 236 | GlobeNewswire (Europe) | BURLINGTON, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) ("Bone Biologics," or the "Company"), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| 19.05. | Bone Biologics extends rhNELL-1 protein shelf life to 29 months | 1 | Investing.com | ||
| 19.05. | Bone Biologics verlängert Haltbarkeit von Protein rhNELL-1 auf 29 Monate | 1 | Investing.com Deutsch | ||
| 08.01. | BONE BIOLOGICS CORPORATION: Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook | 537 | GlobeNewswire (Europe) | BURLINGTON, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| 23.12.25 | BONE BIOLOGICS CORPORATION: Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months | 440 | GlobeNewswire (Europe) | BURLINGTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 7,920 | -1,17 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Legal Officer Transition | NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,067 | 0,00 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| CERENOME | 0,508 | -12,41 % | Cerenome names Ron Andrews as chief business officer | ||
| ATOSSA THERAPEUTICS | 1,950 | +1,04 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2027 Financial Results, Delivering First-ever Net Income Before Income Tax | Total revenue increased 28% for the quarter and 41% for the six months ended September 30, 2026 compared to same periods last yearU.S. revenue increased 93% for the quarter and 113% for the six months... ► Artikel lesen | |
| TANDEM DIABETES | 14,900 | -11,31 % | Tandem Diabetes Care names successor as CEO Sheridan retires | ||
| CO-DIAGNOSTICS | 0,289 | 0,00 % | Co-Diagnostics Reports Third Quarter 2026 Financial Results | Two Regulatory Submissions Under Review in India and the U.S. Third Quarter Operating Expenses Down 12% Year Over YearPlatform Capabilities Expanding with ReadyGo Collaboration, India Connectivity and... ► Artikel lesen | |
| QUIDELORTHO | 10,730 | +3,82 % | QuidelOrtho expects over $80M in 2027 annual savings as it narrows 2026 revenue to $2.52B-$2.54B | ||
| VERU | 2,140 | +0,94 % | Veru executive to present obesity drug data at industry conference | ||
| LIFEWARD | 5,840 | +0,52 % | Lifeward Ltd. - 8-K, Current Report | ||
| CLOVER HEALTH INVESTMENTS | 4,290 | -2,50 % | Clover Health auf der UBS Global Healthcare Conference: Starkes Wachstum trifft auf steigende Ertragskraft | ||
| SENSEONICS | 9,200 | +2,22 % | Senseonics delivers 'breakout quarter' more than doubling Eversense 365 revenue | ||
| TEMPEST THERAPEUTICS | 0,373 | 0,00 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| NANO-X IMAGING | 0,378 | +1,18 % | Nanox.AI signs distribution deal for cardiac imaging in Thailand | ||
| IMUNON | 0,780 | +13,04 % | IMUNON präsentiert translationale Daten aus Phase-2-Studie bei Eierstockkrebs |
BONE BIOLOGICS CORP gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,341 Euro und damit -0,06 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BONE BIOLOGICS CORP finden Sie auf Wallstreet Online.